Home
Live Updates
Pharming Group N.V.: Pharming announces first patient enrolled in pediatric clinical trial of leniolisib : comparemela.com
Pharming Group N.V.: Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/
Related Keywords
Japan ,
United States ,
Netherlands ,
United Kingdom ,
London ,
City Of ,
Amsterdam ,
Noord Holland ,
America ,
American ,
Manish Butte ,
Dennis Riedl ,
Ethan Metelenis ,
Heather Robertson ,
Michael Levitan ,
Dan Caley ,
Anurag Relan ,
E Richard Stiehm ,
Linkedin ,
Vp Investor Relations Corporate Communications ,
Drug Administration ,
Regulatory Agency ,
Nasdaq ,
Exchange Commission ,
American Society Of Hematology ,
Prnewswire Pharming Groupnv ,
European Medicines Agency ,
Department Of Pediatrics ,
Pharming Group ,
Lifespring Life Sciences Communication ,
Committee For Medicinal Products Human Use ,
Investor Relations Corporate Communications ,
Stiehm Endowed Chair ,
Division Chief ,
American Society ,
United Kingdom Medicines ,
Pediatric Investigation Plan ,
Chief Medical Officer ,
New Drug Application ,
Prescription Drug User Fee Act ,
Marketing Authorisation Application ,
Medicinal Products ,
Human Use ,
Activated Phosphoinositide ,
North America ,
Middle East ,
Annual Report ,
Allergy Clin ,
Rev Allergy ,
Investor Relations ,
Corporate Communications ,
Spring Life Sciences Communication ,
Pharming ,
Group ,
Nnounces ,
First ,
Patient ,
Unrolled ,
Pediatric ,
Linical ,
Trial ,
Eniolisib ,
comparemela.com © 2020. All Rights Reserved.